Article
Human glycinamide ribonucleotide transformylase: active site mutants as mechanistic probes.
Biochemistry - 9 Jan 2007
Manieri Wanda, Moore Molly E, Soellner Matthew B, Tsang Pearl, Caperelli Carol A
Abstract excerpt
Human glycinamide ribonucleotide transformylase (GART) (EC 2.1.2.2) is a validated target for cancer chemotherapy, but mechanistic studies of this therapeutically important enzyme are limited. Site-directed mutagenesis, initial velocity studies, pH-rate studies, and substrate binding studies have been employed to probe the role of the strictly conserved active site residues, N106, H108, and D144, and the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
